Matthew Perrone
The Associated Press
Washington, DC, United States
Contact Matthew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matthew:
'Tranq' adds new suffering to opioid drug crisis, but is it driving up deaths?
Xylazine, a powerful animal sedative often called "tranq," is frequently added to fentanyl. Some users say the combination gives a longer-lasting high, while also causing severe skin wounds. → Read More
Abortion clinics in 3 states sue to protect pill access
Abortion providers in three states filed a lawsuit Monday aimed at preserving access to the widely used abortion pill mifepristone → Read More
Access to abortion pill in limbo after competing rulings
Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years → Read More
New FDA rule requires info on breast density with all mammograms
The CDC says about one in eight women will get breast cancer in her lifetime. → Read More
US requires breast density information with all mammograms
The new requirements, finalized Thursday by the Food and Drug Administration, are aimed at standardizing the information given to millions of women following scans to detect breast cancer. → Read More
US requires breast density information with all mammograms
The new requirements, finalized Thursday by the Food and Drug Administration, are aimed at standardizing the information given to millions of women following scans to detect breast cancer. → Read More
Maker of unproven birth drug Makena to pull from US market
The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S. → Read More
Maker of unproven birth drug Makena to pull from US market
Maker of unproven birth drug Makena to pull from US market → Read More
FDA panel narrowly backs Pfizer RSV vaccine for older adults
Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the → Read More
FDA panel narrowly backs Pfizer RSV vaccine for older adults
WASHINGTON (AP) — Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illnes… → Read More
FDA panel narrowly backs Pfizer RSV vaccine for older adults
WASHINGTON (AP) — Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness k... → Read More
FDA’s own reputation could be restraining its misinformation fight
While experts support the FDA's fight against misinformation, they warn that separate controversies at the agency may be undermining its credibility with the public. → Read More
FDA’s own reputation could be restraining its misinfo fight
WASHINGTON (AP) — The government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations. But FDA Commissioner Dr. Robert […] → Read More
FDA’s own reputation could be restraining its misinfo fight
WASHINGTON (AP) — The government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role... → Read More
Panel backs moving opioid antidote Narcan over the counter
Panel backs moving opioid antidote Narcan over the counter → Read More
Panel backs moving opioid antidote Narcan over the counter
WASHINGTON (AP) — The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said Wednesday. The panel of… → Read More
FDA panel unanimously backs moving opioid antidote over the counter
The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said. → Read More
FDA considers making opioid antidote available without prescription
The Food and Drug Administration is meeting with advisers to discuss making the nasal-spray version of Narcan available without a prescription. → Read More
Panel backs moving opioid antidote Narcan over the counter
The overdose-reversal drug naloxone should be available as an over-the-counter medication to aid the national response to the opioid crisis, U.S. health advisers said Wednesday. → Read More
Panel backs moving opioid antidote Narcan over the counter
The overdose-reversal drug naloxone should be available as an over-the-counter medication to aid the national response to the opioid crisis, U.S. health advisers said Wednesday. → Read More